PedAM
Pediatric Disease Annotations & Medicines
| Disease | severe combined immunodeficiency |
| Phenotype | C0024299|lymphoma |
| Sentences | 10 |
| PubMedID- 24634778 | Mouse efficacy studies in scid mice engrafted with disseminated lymphoma showed very high anti-tumor activity that was more than 50-fold more potent than that of rituximab, or the combination of rituximab and il2 [85]. |
| PubMedID- 23326467 | The anti-tumor activity of expanded human nk cells was examined in scid mice injected with human lymphoma cells. |
| PubMedID- 21657960 | Adoptive transfer of the ctls to scid mice loaded with qlvqsgaev(+)/hla-a2.1(+) lymphoma cells effectively inhibited tumor growth. |
| PubMedID- 23316191 | In vivo, administration of lenalidomide and pomalidomide resulted in a significant increase of nk cells in severe combined immunodeficient (scid) mice with human lymphoma xenografts. |
| PubMedID- 23536996 | Cik cell infusion significantly prolongs survival of scid mice injected with human lymphoma cells when compared with control animals injected with tumor cells alone or animals treated with lak cells. |
| PubMedID- 23693095 | The in vivo growth inhibitory effect of rapamycin was also confirmed in scid mice with kmh2 hodgkin-lymphoma xenografts. |
| PubMedID- 23825648 | scid mice injected with hs sultan lymphoma cells were given vehicle (phosphate buffered saline (pbs)) alone, mil-21 alone, rituximab alone, or mil-21 plus rituximab. |
| PubMedID- 25962508 | A preclinical study reported that the survival of severe combined immunodeficient mice injected with human lymphoma cells could be significantly prolonged after receiving cik cell infusion [19]. |
| PubMedID- 22589397 | Severe combined immunodeficient (scid) mice inoculated with human cd27-expressing lymphoma cells were administered 1f5 to investigate direct antitumor effects. |
| PubMedID- 24098639 | Bjab cells were able to develop a human/mouse model of lymphoma in scid mice. |
Page: 1